Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Canna Law Blog

OCTOBER 5, 2022

However, if this recommendation is actually taken up by the government, legitimate medical marijuana products may be imported into Japan under its existing laws for pharmaceuticals and medical devices. Last year, it recommended that the government allow the use of marijuana to treat “refractory epilepsy.”

Marijuana 93

Marijuana Seed-To-Sale Clinical Trials Epilepsy 93

Veriheal

JULY 26, 2023

In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State. Northwest Georgia News also revealed, “Separate from those dispensaries, the 2019 law also authorizes independent pharmacies to sell cannabis oil to eligible patients.”

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

DECEMBER 30, 2019

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

Legislation 59

Legislation Patients Access Banking 59

The Cannigma

JUNE 1, 2021

The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Children may be eligible in cases of refractory epilepsy or cancer.

Law 113

Law Epilepsy Programs Patients 113

Canna Law Blog

MARCH 12, 2019

On January 3, 2019, the PTAB published its Final Written Decision in the case, Insys Development Co, Inc. 9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). GW Pharma”) and Otsuka Pharmaceuticals Co., GW Pharma Ltd., IPR 2017-00503).

Epilepsy 71

Epilepsy Pharmaceutical Cannabinoids CBD 71

Project CBD

FEBRUARY 28, 2023

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy [press release]. Epilepsy Behav. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

FEBRUARY 21, 2023

Opioid Abuse and Drug Overdose Deaths Are Higher in States With Restrictive MMJ Policies Despite ongoing political debates about the limitations of medical marijuana programs, a 2019 study published in the Journal of Patient-Centered Research and Reviews provided further evidence of how MMJ-restrictive states inadvertently impact their patients.

Access 98

Access Patients Chronic Pain Conditions 98

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

MassRoots

JANUARY 10, 2019

House Bill 136, an amendment to legalize medical marijuana, was introduced in the Kentucky Legislature on Wednesday, January 9, 2019. Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms.

Legalization 111

Legalization Marijuana Epilepsy Legislation 111

CannaTech

APRIL 1, 2020

When I was at Pharmacy School at Sydney University, more than 20 years ago, we learned the pharmaceutical and clinical sciences ranging from the design, synthesis, formulation, dispensing and testing of drugs and the clinical and social aspects of pharmacy. And most especially in these times, cannabis is used effectively to treat anxiety.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Millions of individuals are reporting CBD having aided in helping them with: Anxiety.

Pets 59

Pets CBD Research and Development Epilepsy 59

Veriheal

SEPTEMBER 27, 2021

Individuals with this condition have to find ways to deal with the fact that their immune system is attacking the protective sheath of nerve fiber surrounding the nerve cells, putting the body in a state of imbalance that results in muscle spasms, paralysis, disrupted bladder function, mental changes, depression, and even epilepsy.

Treatment 98

Treatment Patients Access Research and Development 98

Veriheal

JANUARY 12, 2023

The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. . Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023.

Medicine 95

Medicine Chronic Pain Consumption Cannabis 95

WeedAdvisor

SEPTEMBER 26, 2019

Created for the treatment of two severe childhood epilepsy disorders – Lennox Gastaut Syndrome (LGS) and Dravet Syndrome – the drug recently received approval for use in the European Union. million in the first half of 2019. Zynerba Pharmaceuticals is currently working on its own CBD medication called Zygel.

CBD 40

CBD Pharmaceutical Research and Development Epilepsy 40

Cannabis Law Report

DECEMBER 14, 2019

12, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) ( PU31.F VANCOUVER, British Columbia, Dec. The UK medicinal cannabis market value is forecast to reach almost US$1.3 billion by 2024.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Cannabis Law Report

NOVEMBER 1, 2021

Since March 2019, Customs and Excise Department officers detected 10 cases in which a total of 194 imported CBD products were found to have traces of THC. Given the wide range of non-pharmaceutical CBD products, there may be other laws applicable to various products. “The city vows zero tolerance to drugs.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. With buzz building across the globe, the momentum will continue into 2019. Even main street brands like Coca-Cola are considering joining the party. “I

Legalization 100

Legalization Research and Development Recreational Data 100

Veriheal

MARCH 23, 2023

Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

CannaMD

JULY 14, 2020

Due to many common pharmaceuticals being tested mainly on younger patients who aren’t dealing with multiple conditions, unforeseen problems often occur when older patients end up being prescribed multiple medications at a time. However, it’s not just older patients who encounter problems with polypharmacy.

Marijuana 105

Marijuana Conditions Patients Epilepsy 105

Cannabis Law Report

MARCH 2, 2020

First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). In March 2019, J&J’s hard work paid off when the FDA approved Spravato for treatment-resistant depression. Fortunately, this issue shouldn’t be a show-stopper.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 206

Marijuana Legalization Programs Oil 206

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

JULY 28, 2021

However, the leadership council of the North Carolina-based Eastern Band of Cherokee Indians made serious headway in May, when the council agreed to legalize small amounts of pharmaceutical-grade cannabis for use on tribal territory. Overview of the Medical Cannabis Bill. Approximately 70% of convicted individuals were of color.

Seed-To-Sale 59

Seed-To-Sale Research and Development Pharmaceutical Conditions 59

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. This article has primarily offered a small dose of the pharmaceutical side of the medical cannabis market in Latin America.

Access 89

Access Patients Pharmaceutical Education 89

Veriheal

JANUARY 15, 2021

In 2019 Ireland’s Health Minister Simon Harris signed legislation known as the Misuse of Drugs, Prescriptions, and Control of Supply of Cannabis for Medical Use Regulations 2019. Severe and Treatment-Resistant Refractory Epilepsy. So does that mean that there is no access to THC for patients in the country? Not exactly.

Legalization 57

Legalization Therapy Access Legislation 57

SpeedWeed

MARCH 30, 2021

Cannabis is no longer a dirty word, and, as it becomes a pharmaceutical product, doctors will then look upon it as a medicine,” Dr Couch added. When robust data is in place, cannabis-based pharmaceutical products will ultimately revolutionise care across a number of indications. Private Clinic Happy To Help. “By

Data 52

Data Patients Clinical Trials Business 52

The Cannigma

OCTOBER 20, 2021

The agency does not have an official list of health conditions that are eligible for treatment with medical cannabis, but the doctor is required to provide justification for why conventional pharmaceuticals won’t suffice for the patient, and their assessment of why the patient may benefit from medical cannabis. In addition, 29.2%

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

JANUARY 15, 2020

million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company. . Following a £7.8 Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

AUGUST 1, 2021

She was prescribed a variety of pharmaceutical drugs, with little success, if any. Paige became an advocate for not only her own daughter, but for other children suffering from intractable epilepsy. Her seizures were constant and long-lasting, landing her in hospice at age of just five. View original article.

Hemp 52

Hemp Extraction Agriculture Strains 52

The Cannigma

MARCH 7, 2022

In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JUNE 26, 2019

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. There is some help in sight, though. Jacel Delgadillo. Eric Stevens.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Refractory paediatric epilepsy. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52